fingolimod hydrochloride has been researched along with lysine in 1 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (lysine) | Trials (lysine) | Recent Studies (post-2010) (lysine) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 37,449 | 622 | 11,213 |
| Protein | Taxonomy | fingolimod hydrochloride (IC50) | lysine (IC50) |
|---|---|---|---|
| Cationic amino acid transporter 3 | Homo sapiens (human) | 158 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chadha, K; George, R; Hojnacki, D; Johnson, J; Kolb, C; Nir, A; Nir, R; Sternberg, Z; Yu, J | 1 |
1 other study(ies) available for fingolimod hydrochloride and lysine
| Article | Year |
|---|---|
Fingolimod anti-inflammatory and neuroprotective effects modulation of RAGE axis in multiple sclerosis patients.
Topics: Adult; Anti-Inflammatory Agents; Antigens, Neoplasm; Arginine; Female; Fingolimod Hydrochloride; HMGB1 Protein; Humans; Lysine; Male; Middle Aged; Mitogen-Activated Protein Kinases; Multiple Sclerosis; Neuroprotective Agents; Receptor for Advanced Glycation End Products; Young Adult | 2018 |